A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...

Detaylı Bibliyografya
Asıl Yazarlar:	Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	American Society for Clinical investigation 2021-08-01
Seri Bilgileri:	JCI Insight
Konular:	Immunology Metabolism
Online Erişim:	https://doi.org/10.1172/jci.insight.149217

Benzer Materyaller

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Yazar:: Ingrid G Rekeland, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
Yazar:: Ingrid G. Rekeland, ve diğerleri
Baskı/Yayın Bilgisi: (2022-01-01)

Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Yazar:: Ingrid G Rekeland, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
Yazar:: Kari Sørland, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Yazar:: Øystein Fluge, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
Yazar:: Sigrid Lunde, ve diğerleri
Baskı/Yayın Bilgisi: (2016-01-01)

No replication of previously reported association with genetic variants in the T cell receptor alpha (TRA) locus for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Yazar:: Marthe Ueland, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
Yazar:: Mella Olav, ve diğerleri
Baskı/Yayın Bilgisi: (2009-07-01)

Medical School Education on Myalgic Encephalomyelitis
Yazar:: Nina Muirhead, ve diğerleri
Baskı/Yayın Bilgisi: (2021-05-01)

Myalgic encephalomyelitis - enigma at the medicine’s crossroads
Yazar:: Pavlović Dragan M., ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Myalgic Encephalomyelitis (ME) or What? An Operational Definition
Yazar:: Frank Twisk
Baskı/Yayın Bilgisi: (2018-09-01)

Myalgic Encephalomyelitis or What? The International Consensus Criteria
Yazar:: Frank Twisk
Baskı/Yayın Bilgisi: (2018-12-01)

The viral origin of myalgic encephalomyelitis/chronic fatigue syndrome.
Yazar:: Maureen R Hanson
Baskı/Yayın Bilgisi: (2023-08-01)

‘The Lightning Process’ and chronic fatigue syndrome/myalgic encephalomyelitis
Yazar:: Rosamund Vallings
Baskı/Yayın Bilgisi: (2022-01-01)

Restricted Spatial Windows of Visibility in Myalgic Encephalomyelitis (ME)
Yazar:: Nadia S. Ahmed, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Visual Aspects of Reading Performance in Myalgic Encephalomyelitis (ME)
Yazar:: Rachel L. Wilson, ve diğerleri
Baskı/Yayın Bilgisi: (2018-08-01)

Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study.
Yazar:: Øystein Fluge, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Missing the meaning and provoking resistance; a case of myalgic encephalomyelitis.
Yazar:: Butler, C, ve diğerleri
Baskı/Yayın Bilgisi: (1996)

Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome
Yazar:: Nadja Scherbakov, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!
Yazar:: Maria Eugenia Ariza
Baskı/Yayın Bilgisi: (2021-01-01)

Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome
Yazar:: Alexandra H. Mandarano, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?
Yazar:: Iñigo Murga Gandasegui, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01)

Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome
Yazar:: Sabine Gravelsina, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Pathological Mechanisms Underlying Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yazar:: Daniel Missailidis, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review
Yazar:: Mateo Cortes Rivera, ve diğerleri
Baskı/Yayın Bilgisi: (2019-08-01)

Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yazar:: Lily Chu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-02-01)

Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Yazar:: Anthony L. Komaroff, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

An Audit of UK Hospital Doctors’ Knowledge and Experience of Myalgic Encephalomyelitis
Yazar:: Keng Ngee Hng, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis
Yazar:: Kenny L. De Meirleir, ve diğerleri
Baskı/Yayın Bilgisi: (2018-11-01)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
Yazar:: Sharpe, M, ve diğerleri
Baskı/Yayın Bilgisi: (2021)

Evidence-based care for people with chronic fatigue syndrome and myalgic encephalomyelitis
Yazar:: White, PD, ve diğerleri
Baskı/Yayın Bilgisi: (2022)

Association between chronic fatigue syndrome/myalgic encephalomyelitis and cardiovascular disease
Yazar:: Mawulorm K. I. Denu, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Tetrahydrobiopterin in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Friend or Foe?
Yazar:: A. F. M. Towheedur Rahman, ve diğerleri
Baskı/Yayın Bilgisi: (2025-01-01)

Cytokines in the Cerebrospinal Fluids of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
Yazar:: D. Peterson, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Development of an expert system for the classification of myalgic encephalomyelitis/chronic fatigue syndrome
Yazar:: Fatma Hilal Yagin, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01)

Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome
Yazar:: Brian Walitt, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Comparison of T-cell receptor diversity of people with myalgic encephalomyelitis versus controls
Yazar:: Joshua J Dibble, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Angina Simultaneously Diagnosed with the Recurrence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yazar:: Koki Li, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yazar:: Alaa Ghali, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Yazar:: Santiago Herrera, ve diğerleri
Baskı/Yayın Bilgisi: (2018-12-01)